1
|
Zuffardi O, Fichera M, Bonaglia MC. The embryo battle against adverse genomes: Are de novo terminal deletions the rescue of unfavorable zygotic imbalances? Eur J Med Genet 2022; 65:104532. [PMID: 35724817 DOI: 10.1016/j.ejmg.2022.104532] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2021] [Revised: 04/02/2022] [Accepted: 05/21/2022] [Indexed: 11/03/2022]
Abstract
De novo distal deletions are structural variants considered to be already present in the zygote. However, investigations especially in the prenatal setting have documented that they are often in mosaic with cell lines in which the same deleted chromosome shows different types of aberrations such as: 1) neutral copy variants with loss of heterozygosity that replace the deleted region with equivalent portions of the homologous chromosome and create distal uniparental disomy (UPD); 2) derivative chromosomes where the deleted one ends with the distal region of another chromosome or has the shape of a ring; 3) U-type mirror dicentric or inv-dup del rearrangements. Unstable dicentrics had already been entailed as causative of terminal deletions even when no trace of the reciprocal inv-dup del had been detected. To clarify the mechanism of origin of distal deletions, we examined PubMed using as keywords: complex/mosaic chromosomal deletions, distal UPD, U-type dicentrics, inv-dup del chromosomes, excluding the recurrent inv-dup del(8p)s which are known to originate by NAHR at the maternal meiosis. The literature has shown that U-type dicentrics leading to nearly complete trisomy and therefore incompatible with zygotic survival underlie many types of de novo unbalanced rearrangements, including terminal deletions. In the early embryo, the position of the postzygotic breaks of the dicentric, the different ways of acquiring telomeres by the broken portions and the selection of the most favorable cell lines in the different tissues determine the prevalence of one or the other rearrangement. Multiple lines with simple terminal deletions, inv-dup dels, unbalanced translocations and segmental UPDs can coexist in various mosaic combinations although it is rare to identify them all in the blood. Regarding the origin of the dicentric, among the 30 cases of non-recurrent inv-dup del with sufficient genotyping information, paternal origin was markedly prevalent with consistently identical polymorphisms within the duplication region, regardless of parental origin. The non-random parental origin made any postzygotic origin unlikely and suggested the occurrence of these dicentrics mainly in spermatogenesis. This study strengthens the evidence that non-recurrent de novo structural rearrangements are often secondary to the rescue of a zygotic genome incompatible with embryo survival.
Collapse
Affiliation(s)
- Orsetta Zuffardi
- Department of Molecular Medicine, University of Pavia, Pavia, Italy.
| | - Marco Fichera
- Department of Biomedical and Biotechnological Sciences, Medical Genetics, University of Catania, Catania, Italy; Oasi Research Institute-IRCCS, Troina, Italy.
| | - Maria Clara Bonaglia
- Cytogenetics Laboratory, Scientific Institute, IRCCS Eugenio Medea, Bosisio Parini, Lecco, Italy.
| |
Collapse
|
2
|
Vibert R, Mignot C, Keren B, Chantot-Bastaraud S, Portnoï MF, Nouguès MC, Moutard ML, Faudet A, Whalen S, Haye D, Garel C, Chatron N, Rossi M, Vincent-Delorme C, Boute O, Delobel B, Andrieux J, Devillard F, Coutton C, Puechberty J, Pebrel-Richard C, Colson C, Gerard M, Missirian C, Sigaudy S, Busa T, Doco-Fenzy M, Malan V, Rio M, Doray B, Sanlaville D, Siffroi JP, Héron D, Heide S. Neurodevelopmental phenotype in 36 new patients with 8p inverted duplication-deletion: Genotype-phenotype correlation for anomalies of the corpus callosum. Clin Genet 2021; 101:307-316. [PMID: 34866188 DOI: 10.1111/cge.14096] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2021] [Revised: 11/26/2021] [Accepted: 12/02/2021] [Indexed: 11/26/2022]
Abstract
Inverted duplication deletion 8p [invdupdel(8p)] is a complex and rare chromosomal rearrangement that combines a distal deletion and an inverted interstitial duplication of the short arm of chromosome 8. Carrier patients usually have developmental delay and intellectual disability (ID), associated with various cerebral and extra-cerebral malformations. Invdupdel(8p) is the most common recurrent chromosomal rearrangement in ID patients with anomalies of the corpus callosum (AnCC). Only a minority of invdupdel(8p) cases reported in the literature to date had both brain cerebral imaging and chromosomal microarray (CMA) with precise breakpoints of the rearrangements, making genotype-phenotype correlation studies for AnCC difficult. In this study, we report the clinical, radiological, and molecular data from 36 new invdupdel(8p) cases including three fetuses and five individuals from the same family, with breakpoints characterized by CMA. Among those, 97% (n = 32/33) of patients presented with mild to severe developmental delay/ID and 34% had seizures with mean age of onset of 3.9 years (2 months-9 years). Moreover, out of the 24 patients with brain MRI and 3 fetuses with neuropathology analysis, 63% (n = 17/27) had AnCC. We review additional data from 99 previously published patients with invdupdel(8p) and compare data of 17 patients from the literature with both CMA analysis and brain imaging to refine genotype-phenotype correlations for AnCC. This led us to refine a region of 5.1 Mb common to duplications of patients with AnCC and discuss potential candidate genes within this region.
Collapse
Affiliation(s)
- Roseline Vibert
- Département de Génétique, Hôpital Armand-Trousseau and Groupe Hospitalier Pitié-Salpêtrière, Centre de Référence Déficiences Intellectuelles de Causes Rares, APHP-Sorbonne Université, Paris, France
| | - Cyril Mignot
- Département de Génétique, Hôpital Armand-Trousseau and Groupe Hospitalier Pitié-Salpêtrière, Centre de Référence Déficiences Intellectuelles de Causes Rares, APHP-Sorbonne Université, Paris, France
| | - Boris Keren
- UF de Génomique du Développement, Département de Génétique, Groupe Hospitalier Pitié-Salpêtrière, APHP-Sorbonne Université, Paris, France
| | | | - Marie-France Portnoï
- Department of Cytogenetics, Armand Trousseau Hospital, APHP-Sorbonne Université, Paris, France
| | - Marie-Christine Nouguès
- Service of Pediatric Neurology, Armand Trousseau Hospital, APHP-Sorbonne Université, Paris, France
| | - Marie-Laure Moutard
- Service of Pediatric Neurology, Armand Trousseau Hospital, APHP-Sorbonne Université, Paris, France
| | - Anne Faudet
- Département de Génétique, Hôpital Armand-Trousseau and Groupe Hospitalier Pitié-Salpêtrière, Centre de Référence Déficiences Intellectuelles de Causes Rares, APHP-Sorbonne Université, Paris, France
| | - Sandra Whalen
- UF de Génétique Clinique et Centre de Référence Maladies Rares des Anomalies du Développement et Syndromes Malformatifs, Hôpital Armand Trousseau, ERN ITHACA, APHP-Sorbonne Université, Paris, France
| | - Damien Haye
- Département de Génétique, Hôpital Armand-Trousseau and Groupe Hospitalier Pitié-Salpêtrière, Centre de Référence Déficiences Intellectuelles de Causes Rares, APHP-Sorbonne Université, Paris, France
| | - Catherine Garel
- Department of Radiology, Armand Trousseau Hospital, APHP-Sorbonne Université, Paris, France
| | - Nicolas Chatron
- Departments of Genetics, Lyon University Hospitals, Lyon, France
| | - Massimiliano Rossi
- Genetics Department, Referral Centre for Developmental Abnormalities, Lyon University Hospital, and INSERM U1028, CNRS UMR5292, Lyon Neuroscience Research Centre, GENDEV Team, Claude Bernard Lyon 1 University, Bron, France
| | | | - Odile Boute
- Service of Clinical Genetic, Jeanne de Flandre Hospital, Lille, France
| | - Bruno Delobel
- Service of Cytogenetics, Institut Catholique de Lille, Lille, France
| | - Joris Andrieux
- Institute of Medical Genetics, Jeanne de Flandre Hospital, Lille, France
| | - Françoise Devillard
- Service de Génétique, Génomique, et Procréation, Centre Hospitalier Universitaire Grenoble Alpes, 38700 La Tronche, France; INSERM 1209, CNRS UMR 5309, Institute for Advanced Biosciences, Université Grenoble Alpes, Grenoble, France
| | - Charles Coutton
- Service de Génétique, Génomique, et Procréation, Centre Hospitalier Universitaire Grenoble Alpes, 38700 La Tronche, France; INSERM 1209, CNRS UMR 5309, Institute for Advanced Biosciences, Université Grenoble Alpes, Grenoble, France
| | - Jacques Puechberty
- Department of Medical Genetics, Arnaud de Villeneuve Hospital, Montpellier, France
| | - Céline Pebrel-Richard
- Service of Cytogenetic, Clermont-Ferrand's University Hospital, Clermont-Ferrand, France
| | - Cindy Colson
- Service of Clinical Genetic, Caen's University Hospital, Caen, France
| | - Marion Gerard
- Service of Clinical Genetic, Caen's University Hospital, Caen, France
| | - Chantal Missirian
- APHM, Laboratory of Genetic, Timone Enfants' Hospital, Marseille, France
| | - Sabine Sigaudy
- Department of Medical Genetics, Timone Enfants' Hospital, Marseille, France
| | - Tiffany Busa
- Department of Medical Genetics, Timone Enfants' Hospital, Marseille, France
| | | | - Valérie Malan
- APHP, Service de Médecine Génomique, Hôpital Necker-Enfants Malades, Paris, Université de Paris, Paris, France
| | - Marlène Rio
- Department of Genetics, Hôpital Necker-Enfants Malades, AP-HP, Paris, France
| | - Bérénice Doray
- Service of Genetic, Felix Guyon Hospital, La Réunion, France
| | | | - Jean-Pierre Siffroi
- Department of Cytogenetics, Armand Trousseau Hospital, APHP-Sorbonne Université, Paris, France
| | - Delphine Héron
- Département de Génétique, Hôpital Armand-Trousseau and Groupe Hospitalier Pitié-Salpêtrière, Centre de Référence Déficiences Intellectuelles de Causes Rares, APHP-Sorbonne Université, Paris, France
| | - Solveig Heide
- Département de Génétique, Hôpital Armand-Trousseau and Groupe Hospitalier Pitié-Salpêtrière, Centre de Référence Déficiences Intellectuelles de Causes Rares, APHP-Sorbonne Université, Paris, France
| |
Collapse
|
3
|
Lo Bianco M, Vecchio D, Timpanaro TA, Arena A, Macchiaiolo M, Bartuli A, Sciuto L, Presti S, Sciuto S, Sapuppo A, Fiumara A, Marino L, Messina G, Pavone P. Deciphering the Invdupdel(8p) Genotype-Phenotype Correlation: Our Opinion. Brain Sci 2020; 10:brainsci10070451. [PMID: 32679641 PMCID: PMC7408450 DOI: 10.3390/brainsci10070451] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2020] [Revised: 07/05/2020] [Accepted: 07/10/2020] [Indexed: 01/30/2023] Open
Abstract
The 8p inverted duplication/deletion is a rare chromosomal rearrangement clinically featuring neurodevelopmental delay, mild to severe cognitive impairment, heart congenital defects and brain abnormalities. Patients affected also present typical facial dysmorphisms and skeletal malformations, and it is thought that the composite clinical picture may fall into the chromosomal rearrangement architecture. With the major aim of better framing its related clinical and diagnostic paths, we describe a patient carrying a de novo invdupde[8p] whose clinical features have not been described so far. Hence, through an extensive genotype-phenotype correlation analysis and by reviewing the dedicated scientific literature, we compared our patient's features with those reported in other patients, which allows us to place our proband's expressiveness in an intermediate area, widening the scope of the already known invdupde[8p] genotype-phenotype relationship.
Collapse
Affiliation(s)
- Manuela Lo Bianco
- Postgraduate Training Program in Pediatrics, Department of Clinical and Experimental Medicine, University of Catania, 95100 Catania, Italy; (L.S.); (S.P.); (S.S.); (A.S.); (L.M.); (G.M.)
- Correspondence: (M.L.B.); (P.P.); Tel.: +39-3401841225 (M.L.B.); +39-0953781193 (P.P.)
| | - Davide Vecchio
- Rare Disease and Medical Genetics, Academic Department of Pediatrics, Bambino Gesù Children’s Hospital, 00146 Rome, Italy; (D.V.); (M.M.); (A.B.)
| | - Tiziana A. Timpanaro
- Department of Clinical and Experimental Medicine, University of Catania, 95100 Catania, Italy; (T.A.T.); (A.A.); (A.F.)
| | - Alessia Arena
- Department of Clinical and Experimental Medicine, University of Catania, 95100 Catania, Italy; (T.A.T.); (A.A.); (A.F.)
| | - Marina Macchiaiolo
- Rare Disease and Medical Genetics, Academic Department of Pediatrics, Bambino Gesù Children’s Hospital, 00146 Rome, Italy; (D.V.); (M.M.); (A.B.)
| | - Andrea Bartuli
- Rare Disease and Medical Genetics, Academic Department of Pediatrics, Bambino Gesù Children’s Hospital, 00146 Rome, Italy; (D.V.); (M.M.); (A.B.)
| | - Laura Sciuto
- Postgraduate Training Program in Pediatrics, Department of Clinical and Experimental Medicine, University of Catania, 95100 Catania, Italy; (L.S.); (S.P.); (S.S.); (A.S.); (L.M.); (G.M.)
| | - Santiago Presti
- Postgraduate Training Program in Pediatrics, Department of Clinical and Experimental Medicine, University of Catania, 95100 Catania, Italy; (L.S.); (S.P.); (S.S.); (A.S.); (L.M.); (G.M.)
| | - Sarah Sciuto
- Postgraduate Training Program in Pediatrics, Department of Clinical and Experimental Medicine, University of Catania, 95100 Catania, Italy; (L.S.); (S.P.); (S.S.); (A.S.); (L.M.); (G.M.)
| | - Annamaria Sapuppo
- Postgraduate Training Program in Pediatrics, Department of Clinical and Experimental Medicine, University of Catania, 95100 Catania, Italy; (L.S.); (S.P.); (S.S.); (A.S.); (L.M.); (G.M.)
| | - Agata Fiumara
- Department of Clinical and Experimental Medicine, University of Catania, 95100 Catania, Italy; (T.A.T.); (A.A.); (A.F.)
| | - Lidia Marino
- Postgraduate Training Program in Pediatrics, Department of Clinical and Experimental Medicine, University of Catania, 95100 Catania, Italy; (L.S.); (S.P.); (S.S.); (A.S.); (L.M.); (G.M.)
| | - Giulia Messina
- Postgraduate Training Program in Pediatrics, Department of Clinical and Experimental Medicine, University of Catania, 95100 Catania, Italy; (L.S.); (S.P.); (S.S.); (A.S.); (L.M.); (G.M.)
| | - Piero Pavone
- Department of Clinical and Experimental Medicine, University of Catania, 95100 Catania, Italy; (T.A.T.); (A.A.); (A.F.)
- Correspondence: (M.L.B.); (P.P.); Tel.: +39-3401841225 (M.L.B.); +39-0953781193 (P.P.)
| |
Collapse
|
4
|
De novo unbalanced translocations have a complex history/aetiology. Hum Genet 2018; 137:817-829. [DOI: 10.1007/s00439-018-1941-9] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2018] [Accepted: 09/24/2018] [Indexed: 12/21/2022]
|
5
|
Knijnenburg J, Uytdewilligen ME, van Hassel DA, Oostenbrink R, Eussen BH, de Klein A, Brooks AS, van Zutven LJ. Postzygotic telomere capture causes segmental UPD, duplication and deletion of chromosome 8p in a patient with intellectual disability and obesity. Eur J Med Genet 2017; 60:445-450. [DOI: 10.1016/j.ejmg.2017.06.003] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2016] [Revised: 03/13/2017] [Accepted: 06/06/2017] [Indexed: 01/30/2023]
|
6
|
García-Santiago FA, Martínez-Glez V, Santos F, García-Miñaur S, Mansilla E, Meneses AG, Rosell J, Granero ÁP, Vallespín E, Fernández L, Sierra B, Oliver-Bonet M, Palomares M, de Torres ML, Mori MÁ, Nevado J, Heath KE, Delicado A, Lapunzina P. Analysis of invdupdel(8p) rearrangement: Clinical, cytogenetic and molecular characterization. Am J Med Genet A 2015; 167A:1018-25. [DOI: 10.1002/ajmg.a.36879] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2014] [Accepted: 10/22/2014] [Indexed: 01/30/2023]
Affiliation(s)
- Fe Amalia García-Santiago
- Cytogenetics Unit, Institute of Medical and Molecular Genetics (INGEMM); IdiPAZ, Hospital Universitario La Paz; Madrid Spain
| | - Víctor Martínez-Glez
- Functional and Structural Genomics Unit, Institute of Medical and Molecular Genetics (INGEMM); IdiPAZ, Hospital Universitario La Paz; Madrid Spain
- CIBERER; Centro de Investigación Biomédica en Red de Enfermedades Raras; ISCIII; Madrid Spain
| | - Fernando Santos
- Clinical Gentics Unit, Institute of Medical and Molecular Genetics (INGEMM); IdiPAZ, Hospital Universitario La Paz; Madrid Spain
- CIBERER; Centro de Investigación Biomédica en Red de Enfermedades Raras; ISCIII; Madrid Spain
| | - Sixto García-Miñaur
- Clinical Gentics Unit, Institute of Medical and Molecular Genetics (INGEMM); IdiPAZ, Hospital Universitario La Paz; Madrid Spain
- CIBERER; Centro de Investigación Biomédica en Red de Enfermedades Raras; ISCIII; Madrid Spain
| | - Elena Mansilla
- Cytogenetics Unit, Institute of Medical and Molecular Genetics (INGEMM); IdiPAZ, Hospital Universitario La Paz; Madrid Spain
- CIBERER; Centro de Investigación Biomédica en Red de Enfermedades Raras; ISCIII; Madrid Spain
| | | | - Jordi Rosell
- CIBERER; Centro de Investigación Biomédica en Red de Enfermedades Raras; ISCIII; Madrid Spain
- Genetics Unit; Hospital Son Espases; Palma de Mallorca; Spain
| | | | - Elena Vallespín
- Functional and Structural Genomics Unit, Institute of Medical and Molecular Genetics (INGEMM); IdiPAZ, Hospital Universitario La Paz; Madrid Spain
- CIBERER; Centro de Investigación Biomédica en Red de Enfermedades Raras; ISCIII; Madrid Spain
| | - Luis Fernández
- Functional and Structural Genomics Unit, Institute of Medical and Molecular Genetics (INGEMM); IdiPAZ, Hospital Universitario La Paz; Madrid Spain
- CIBERER; Centro de Investigación Biomédica en Red de Enfermedades Raras; ISCIII; Madrid Spain
| | - Blanca Sierra
- Genetics Unit; Hospital Son Espases; Palma de Mallorca; Spain
| | | | - María Palomares
- Functional and Structural Genomics Unit, Institute of Medical and Molecular Genetics (INGEMM); IdiPAZ, Hospital Universitario La Paz; Madrid Spain
- CIBERER; Centro de Investigación Biomédica en Red de Enfermedades Raras; ISCIII; Madrid Spain
| | - María Luisa de Torres
- Cytogenetics Unit, Institute of Medical and Molecular Genetics (INGEMM); IdiPAZ, Hospital Universitario La Paz; Madrid Spain
- CIBERER; Centro de Investigación Biomédica en Red de Enfermedades Raras; ISCIII; Madrid Spain
| | - María Ángeles Mori
- Functional and Structural Genomics Unit, Institute of Medical and Molecular Genetics (INGEMM); IdiPAZ, Hospital Universitario La Paz; Madrid Spain
- CIBERER; Centro de Investigación Biomédica en Red de Enfermedades Raras; ISCIII; Madrid Spain
| | - Julián Nevado
- Functional and Structural Genomics Unit, Institute of Medical and Molecular Genetics (INGEMM); IdiPAZ, Hospital Universitario La Paz; Madrid Spain
- CIBERER; Centro de Investigación Biomédica en Red de Enfermedades Raras; ISCIII; Madrid Spain
| | - Karen E. Heath
- Molecular Endocrinology Unit, Institute of Medical and Molecular Genetics (INGEMM); IdiPAZ, Hospital Universitario La Paz; Madrid Spain
- CIBERER; Centro de Investigación Biomédica en Red de Enfermedades Raras; ISCIII; Madrid Spain
| | - Alicia Delicado
- Cytogenetics Unit, Institute of Medical and Molecular Genetics (INGEMM); IdiPAZ, Hospital Universitario La Paz; Madrid Spain
- CIBERER; Centro de Investigación Biomédica en Red de Enfermedades Raras; ISCIII; Madrid Spain
| | - Pablo Lapunzina
- Clinical Gentics Unit, Institute of Medical and Molecular Genetics (INGEMM); IdiPAZ, Hospital Universitario La Paz; Madrid Spain
- CIBERER; Centro de Investigación Biomédica en Red de Enfermedades Raras; ISCIII; Madrid Spain
| |
Collapse
|
7
|
Shimizu K, Wakui K, Kosho T, Okamoto N, Mizuno S, Itomi K, Hattori S, Nishio K, Samura O, Kobayashi Y, Kako Y, Arai T, Tsutomu OI, Kawame H, Narumi Y, Ohashi H, Fukushima Y. Microarray and FISH-based genotype-phenotype analysis of 22 Japanese patients with Wolf-Hirschhorn syndrome. Am J Med Genet A 2013; 164A:597-609. [PMID: 24357569 DOI: 10.1002/ajmg.a.36308] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2013] [Accepted: 09/30/2013] [Indexed: 01/17/2023]
Abstract
Wolf-Hirschhorn syndrome (WHS) is a contiguous gene deletion syndrome of the distal 4p chromosome, characterized by craniofacial features, growth impairment, intellectual disability, and seizures. Although genotype-phenotype correlation studies have previously been published, several important issues remain to be elucidated including seizure severity. We present detailed clinical and molecular-cytogenetic findings from a microarray and fluorescence in situ hybridization (FISH)-based genotype-phenotype analysis of 22 Japanese WHS patients, the first large non-Western series. 4p deletions were terminal in 20 patients and interstitial in two, with deletion sizes ranging from 2.06 to 29.42 Mb. The new Wolf-Hirschhorn syndrome critical region (WHSCR2) was deleted in all cases, and duplication of other chromosomal regions occurred in four. Complex mosaicism was identified in two cases: two different 4p terminal deletions; a simple 4p terminal deletion and an unbalanced translocation with the same 4p breakpoint. Seizures began in infancy in 33% (2/6) of cases with small (<6 Mb) deletions and in 86% (12/14) of cases with larger deletions (>6 Mb). Status epilepticus occurred in 17% (1/6) with small deletions and in 87% (13/15) with larger deletions. Renal hypoplasia or dysplasia and structural ocular anomalies were more prevalent in those with larger deletions. A new susceptible region for seizure occurrence is suggested between 0.76 and 1.3 Mb from 4 pter, encompassing CTBP1 and CPLX1, and distal to the previously-supposed candidate gene LETM1. The usefulness of bromide therapy for seizures and additional clinical features including hypercholesterolemia are also described.
Collapse
Affiliation(s)
- Kenji Shimizu
- Department of Medical Genetics, Shinshu University School of Medicine, Matsumoto, Japan; Division of Medical Genetics, Saitama Children's Medical Center, Saitama, Japan
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Baranello G, Cesaretti C, Zambonin F, Casalone R, Granata P, Esposito S, Alfei E, Natacci F. Partial Trisomy 13 and Partial Monosomy 8 Mosaicism Secondary to an Unbalanced De Novo Translocation: Highlighting an Uncommon Chromosomal Abnormality. J Child Neurol 2013; 28:1463-1466. [PMID: 23611886 DOI: 10.1177/0883073813483571] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Few cases of mosaicism involving a normal cell line and an unbalanced autosomal translocation have been reported so far. No cases of partial trisomy 13 and partial monosomy 8 mosaicism have been published. The authors report a new patient with partial trisomy 13 and partial monosomy 8 mosaicism due to an unbalanced translocation (13/8). A postzygotic mitotic exchange of nonhomologous chromatids followed by the loss of one of the translocated chromatids has been hypothesized as the potential underlying mechanism. Although a clear correlation of the clinical features of the patient with his chromosomal abnormality can be challenging, dysmorphic features, hyperactive behavior, moderate developmental delay, and tonic-clonic seizures can be interpreted as secondary to the particular genotype of the patient. These findings should be taken into account in the diagnostic process of patients presenting with multiple congenital anomalies and/or mental retardation conditions.
Collapse
Affiliation(s)
- Giovanni Baranello
- 1UO Neurologia dello Sviluppo, Fondazione IRCCS Istituto Neurologico "C Besta", Milan, Italy
| | | | | | | | | | | | | | | |
Collapse
|
9
|
Independent post-zygotic breaks of a dicentric chromosome result in mosaicism for an inverted duplication deletion 9p and terminal deletion 9p. Eur J Med Genet 2013; 56:229-35. [PMID: 23416622 DOI: 10.1016/j.ejmg.2013.01.013] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2012] [Accepted: 01/22/2013] [Indexed: 01/30/2023]
Abstract
Mosaicism with two cell lines having different rearrangements of the same chromosome is rare. Only a few cases of mosaicism have been described in association with chromosomal inverted duplication deletion (inv dup del) rearrangements. A well-established mechanism of formation of inv dup del rearrangements involves a dicentric intermediate, which undergoes breakage during cell division, generating cells with either an inv dup del or a simple deletion. A patient with developmental delay and dysmorphic features was found to carry two cell lines with rearrangements of 9p: an inv dup del 9p and a terminal deletion 9p. Microarray and FISH analysis showed that these cell lines do not constitute the reciprocal products of a single dicentric breakage event. We propose that independent post-zygotic breaks of a dicentric chromosome as a likely mechanism leading to the generation of the observed cell lines. The post-zygotic origin of the inv dup del rearrangements and the associated mosaicism can be a more frequent phenomenon than currently appreciated. Therefore, genotype-phenotype correlations in the inv dup del rearrangements need to take into account the possible presence of other abnormal cell lines during early development.
Collapse
|
10
|
Chen CP, Su YN, Chern SR, Hsu CY, Tsai FJ, Wu PC, Lee CC, Chen YT, Lee MS, Wang W. Inv dup del(9p): prenatal diagnosis and molecular cytogenetic characterization by fluorescence in situ hybridization and array comparative genomic hybridization. Taiwan J Obstet Gynecol 2011; 50:67-73. [PMID: 21482378 DOI: 10.1016/j.tjog.2011.01.038] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/11/2010] [Indexed: 11/28/2022] Open
Abstract
OBJECTIVE To present molecular cytogenetic characterization of prenatally detected inverted duplication and deletion of 9p, or inv dup del(9p). MATERIALS, METHODS, AND RESULTS A 35-year-old primigravid woman underwent amniocentesis at 16 weeks of gestation because of advanced maternal age. Amniocentesis revealed a derivative chromosome 9, or der(9) with additional material at the end of the short arm of one chromosome 9. Parental karyotypes were normal. Level II ultrasound showed ventriculomegaly and normal male external genitalia. Repeated amniocentesis was performed at 20 weeks of gestation. Array comparative genomic hybridization revealed a 0.70-Mb deletion at 9p24.3 and an 18.36-Mb duplication from 9p24.3 to 9p22.1. The distal 9p deletion encompassed the genes of DOCK8, ANKRD15, FOXD4, DMRT1, and DMRT3. Fluorescence in situ hybridization analysis using bacterial artificial chromosome clone probes specific for 9p confirmed that the der(9) was derived from the inv dup del(9p). The karyotype of the fetus was 46,XY,inv dup del(9)(:p22.1-->p24.3::p24.3-->qter)dn or 46,XY,der(9) del(9)(p24.3) inv dup(9)(p22.1p24.3)dn. Polymorphic DNA marker analysis determined a maternal origin of the inv dup del(9p). A 512-g male fetus was subsequently terminated at 22 weeks of gestation with facial dysmorphism. The fetus had normal male external genitalia without sex reversal. CONCLUSION Fluorescence in situ hybridization and array comparative genomic hybridization are useful to determine the nature of a prenatally detected aberrant chromosome derived from the inv dup del. Male fetuses with inv dup del(9p) and haploinsufficiency of DMRT1 and DMRT3 may present normal male external genitalia without sex reversal.
Collapse
Affiliation(s)
- Chih-Ping Chen
- Department of Obstetrics and Gynecology, Mackay Memorial Hospital, Taipei, Taiwan.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Genotype-phenotype association studies of chromosome 8p inverted duplication deletion syndrome. Behav Genet 2011; 41:373-80. [PMID: 21259039 DOI: 10.1007/s10519-011-9447-4] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2010] [Accepted: 01/07/2011] [Indexed: 10/18/2022]
Abstract
Individuals diagnosed with chromosome 8p inverted duplication deletion (invdupdel(8p)) manifest a wide range of clinical features and cognitive impairment. The purpose of this study is to employ array CGH technology to define more precisely the cytogenetic breakpoints and regions of copy number variation found in several individuals with invdupdel(8p), and compare these results with their neuropsychological characteristics. We examined the cognitive-behavioral features of two male and two female children, ages 3-15 years, with invdupdel(8p). We noted cognitive deficits that ranged from mild to severe, and adaptive behavior composites that ranged from significantly to substantially lower than adequate levels. CARS scores, a measure of autistic behavior, identified three children with autism or autistic-like features. Three of the four children exhibited attention deficits and hyperactivity consistent with a DSM-IV-TR diagnosis of ADHD. One child showed extreme emotional lability. Interestingly, intellectual disability was not correlated with deletion size, nor was the deletion location associated with the autistic phenotype. On the other hand, the duplication length in 8p21.1/8p22 was associated with cognitive deficit. In addition, a small locus of over-expression in 8p21.3 was common for all three participants diagnosed as autistic. A limitation of the study is its small sample size. Further analyses of the deleted and over-expressed regions are needed to ascertain the genes involved in cognitive function and, possibly, autism.
Collapse
|